b'<?xml version="1.0" ?>\n<!DOCTYPE PubmedArticleSet PUBLIC "-//NLM//DTD PubMedArticle, 1st January 2019//EN" "https://dtd.nlm.nih.gov/ncbi/pubmed/out/pubmed_190101.dtd">\n<PubmedArticleSet>\n<PubmedArticle>\n    <MedlineCitation Status="MEDLINE" IndexingMethod="Curated" Owner="NLM">\n        <PMID Version="1">31112844</PMID>\n        <DateCompleted>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>30</Day>\n        </DateCompleted>\n        <DateRevised>\n            <Year>2020</Year>\n            <Month>03</Month>\n            <Day>30</Day>\n        </DateRevised>\n        <Article PubModel="Print-Electronic">\n            <Journal>\n                <ISSN IssnType="Electronic">1573-2517</ISSN>\n                <JournalIssue CitedMedium="Internet">\n                    <Volume>254</Volume>\n                    <PubDate>\n                        <Year>2019</Year>\n                        <Month>07</Month>\n                        <Day>01</Day>\n                    </PubDate>\n                </JournalIssue>\n                <Title>Journal of affective disorders</Title>\n                <ISOAbbreviation>J Affect Disord</ISOAbbreviation>\n            </Journal>\n            <ArticleTitle>Antidepressant pharmacogenetics in children and young adults: A systematic review.</ArticleTitle>\n            <Pagination>\n                <MedlinePgn>98-108</MedlinePgn>\n            </Pagination>\n            <ELocationID EIdType="pii" ValidYN="Y">S0165-0327(19)30348-9</ELocationID>\n            <ELocationID EIdType="doi" ValidYN="Y">10.1016/j.jad.2019.05.025</ELocationID>\n            <Abstract>\n                <AbstractText Label="OBJECTIVE">Antidepressants are frequently prescribed and are the first-line pharmacological treatments for psychiatric disorders in children and adolescents. Although antidepressants are generally effective and well-tolerated by children, between 31% to 48% will not respond and up to 25% will experience an adverse drug reaction. Evidence from adult populations suggests pharmacogenetic information can assist with identifying individuals at greatest risk for poor response or adverse drug reactions but the evidence base in pediatric populations is less clear.</AbstractText>\n                <AbstractText Label="METHOD">We systematically identified, reviewed, and critically evaluated the antidepressant pharmacogenetics literature among children and adolescents using standardized tools and consensus criteria.</AbstractText>\n                <AbstractText Label="RESULTS">We identified 24 studies, most of which were of fair to moderate quality. Collectively, the studies identified 25 significant gene-antidepressant associations involving 10 genes (ABCB1, BDNF, CYP2C19, CYP2D6, FKBP5, GNB3, HTR1B, HTR2A, SLC6A4, TPH2) and nine antidepressants (amitriptyline, citalopram, escitalopram, fluoxetine, fluvoxamine, nortriptyline, paroxetine, sertraline, and venlafaxine). None of the identified associations have been independently replicated in children.</AbstractText>\n                <AbstractText Label="LIMITATIONS">Included studies were heterogenous in terms of study design, genes and drugs assessed, and outcomes measured.</AbstractText>\n                <AbstractText Label="CONCLUSION">The antidepressant pharmacogenetics knowledge base in pediatric populations is still emerging, but results to date echo many of the gene-antidepressant associations identified in adult populations. Given ubiquitous prescribing of antidepressants in the care of children and adolescents with\xc2\xa0psychiatric disorders, further research on identifying new and confirming current gene-antidepressant associations are warranted.</AbstractText>\n                <CopyrightInformation>Copyright \xc2\xa9 2019 Elsevier B.V. All rights reserved.</CopyrightInformation>\n            </Abstract>\n            <AuthorList CompleteYN="Y">\n                <Author ValidYN="Y">\n                    <LastName>Maruf</LastName>\n                    <ForeName>Abdullah Al</ForeName>\n                    <Initials>AA</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Greenslade</LastName>\n                    <ForeName>Alexandra</ForeName>\n                    <Initials>A</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Department of Kinesiology, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Arnold</LastName>\n                    <ForeName>Paul D</ForeName>\n                    <Initials>PD</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Department of Psychiatry, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Department of Medical Genetics, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n                <Author ValidYN="Y">\n                    <LastName>Bousman</LastName>\n                    <ForeName>Chad</ForeName>\n                    <Initials>C</Initials>\n                    <AffiliationInfo>\n                        <Affiliation>Mathison Centre for Mental Health Research and Education, Hotchkiss Brain Institute, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Department of Psychiatry, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Department of Medical Genetics, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Department of Physiology and Pharmacology, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada; Alberta Children\'s Hospital Research Institute, Cumming School of Medicine, Univeristy of Calgary, Calgary, AB, T2N 4N1, Canada. Electronic address: chad.bousman@ucalagary.ca.</Affiliation>\n                    </AffiliationInfo>\n                </Author>\n            </AuthorList>\n            <Language>eng</Language>\n            <PublicationTypeList>\n                <PublicationType UI="D016428">Journal Article</PublicationType>\n                <PublicationType UI="D013485">Research Support, Non-U.S. Gov\'t</PublicationType>\n                <PublicationType UI="D000078182">Systematic Review</PublicationType>\n            </PublicationTypeList>\n            <ArticleDate DateType="Electronic">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>14</Day>\n            </ArticleDate>\n        </Article>\n        <MedlineJournalInfo>\n            <Country>Netherlands</Country>\n            <MedlineTA>J Affect Disord</MedlineTA>\n            <NlmUniqueID>7906073</NlmUniqueID>\n            <ISSNLinking>0165-0327</ISSNLinking>\n        </MedlineJournalInfo>\n        <ChemicalList>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D000928">Antidepressive Agents</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="C493230">SLC6A4 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0</RegistryNumber>\n                <NameOfSubstance UI="D050486">Serotonin Plasma Membrane Transport Proteins</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>01K63SUP8D</RegistryNumber>\n                <NameOfSubstance UI="D005473">Fluoxetine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>0DHU5B8D6V</RegistryNumber>\n                <NameOfSubstance UI="D015283">Citalopram</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>1806D8D52K</RegistryNumber>\n                <NameOfSubstance UI="D000639">Amitriptyline</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>41VRH5220H</RegistryNumber>\n                <NameOfSubstance UI="D017374">Paroxetine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>7D7RX5A8MO</RegistryNumber>\n                <NameOfSubstance UI="D000069470">Venlafaxine Hydrochloride</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>BL03SY4LXB</RegistryNumber>\n                <NameOfSubstance UI="D009661">Nortriptyline</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.14.1</RegistryNumber>\n                <NameOfSubstance UI="C045793">CYP2C19 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.14.1</RegistryNumber>\n                <NameOfSubstance UI="D065731">Cytochrome P-450 CYP2C19</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.14.1</RegistryNumber>\n                <NameOfSubstance UI="D019389">Cytochrome P-450 CYP2D6</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.16.4</RegistryNumber>\n                <NameOfSubstance UI="C494784">TPH2 protein, human</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>EC 1.14.16.4</RegistryNumber>\n                <NameOfSubstance UI="D014365">Tryptophan Hydroxylase</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>O4L1XPO44W</RegistryNumber>\n                <NameOfSubstance UI="D016666">Fluvoxamine</NameOfSubstance>\n            </Chemical>\n            <Chemical>\n                <RegistryNumber>QUC7NX6WMB</RegistryNumber>\n                <NameOfSubstance UI="D020280">Sertraline</NameOfSubstance>\n            </Chemical>\n        </ChemicalList>\n        <CitationSubset>IM</CitationSubset>\n        <MeshHeadingList>\n            <MeshHeading>\n                <DescriptorName UI="D000293" MajorTopicYN="N">Adolescent</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000639" MajorTopicYN="N">Amitriptyline</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000928" MajorTopicYN="N">Antidepressive Agents</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="Y">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D002648" MajorTopicYN="N">Child</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D015283" MajorTopicYN="N">Citalopram</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D065731" MajorTopicYN="N">Cytochrome P-450 CYP2C19</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D019389" MajorTopicYN="N">Cytochrome P-450 CYP2D6</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005260" MajorTopicYN="N">Female</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D005473" MajorTopicYN="N">Fluoxetine</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D016666" MajorTopicYN="N">Fluvoxamine</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D006801" MajorTopicYN="N">Humans</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D008297" MajorTopicYN="N">Male</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D001523" MajorTopicYN="N">Mental Disorders</DescriptorName>\n                <QualifierName UI="Q000188" MajorTopicYN="Y">drug therapy</QualifierName>\n                <QualifierName UI="Q000235" MajorTopicYN="Y">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D009661" MajorTopicYN="N">Nortriptyline</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D017374" MajorTopicYN="N">Paroxetine</DescriptorName>\n                <QualifierName UI="Q000009" MajorTopicYN="N">adverse effects</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D010597" MajorTopicYN="Y">Pharmacogenetics</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D050486" MajorTopicYN="N">Serotonin Plasma Membrane Transport Proteins</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D020280" MajorTopicYN="N">Sertraline</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D014365" MajorTopicYN="N">Tryptophan Hydroxylase</DescriptorName>\n                <QualifierName UI="Q000235" MajorTopicYN="N">genetics</QualifierName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D000069470" MajorTopicYN="N">Venlafaxine Hydrochloride</DescriptorName>\n            </MeshHeading>\n            <MeshHeading>\n                <DescriptorName UI="D055815" MajorTopicYN="N">Young Adult</DescriptorName>\n            </MeshHeading>\n        </MeshHeadingList>\n        <KeywordList Owner="NOTNLM">\n            <Keyword MajorTopicYN="Y">Adverse drug reaction</Keyword>\n            <Keyword MajorTopicYN="Y">Antidepressants</Keyword>\n            <Keyword MajorTopicYN="Y">Efficacy</Keyword>\n            <Keyword MajorTopicYN="Y">Pediatric</Keyword>\n            <Keyword MajorTopicYN="Y">Pharmacogenomics</Keyword>\n        </KeywordList>\n    </MedlineCitation>\n    <PubmedData>\n        <History>\n            <PubMedPubDate PubStatus="received">\n                <Year>2019</Year>\n                <Month>02</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="revised">\n                <Year>2019</Year>\n                <Month>04</Month>\n                <Day>25</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="accepted">\n                <Year>2019</Year>\n                <Month>05</Month>\n                <Day>12</Day>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="pubmed">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="medline">\n                <Year>2020</Year>\n                <Month>3</Month>\n                <Day>31</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n            <PubMedPubDate PubStatus="entrez">\n                <Year>2019</Year>\n                <Month>5</Month>\n                <Day>22</Day>\n                <Hour>6</Hour>\n                <Minute>0</Minute>\n            </PubMedPubDate>\n        </History>\n        <PublicationStatus>ppublish</PublicationStatus>\n        <ArticleIdList>\n            <ArticleId IdType="pubmed">31112844</ArticleId>\n            <ArticleId IdType="pii">S0165-0327(19)30348-9</ArticleId>\n            <ArticleId IdType="doi">10.1016/j.jad.2019.05.025</ArticleId>\n        </ArticleIdList>\n    </PubmedData>\n</PubmedArticle>\n\n</PubmedArticleSet>'